戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 mprinting-related fetal overgrowth disorder, Beckwith-Wiedemann syndrome.
2 , with six patients not showing phenotype of Beckwith-Wiedemann syndrome.
3 , are both implicated in the pathogenesis of Beckwith-Wiedemann syndrome.
4 line balanced chromosomal rearrangements and Beckwith-Wiedemann syndrome.
5  diseases associated with imprinting such as Beckwith-Wiedemann syndrome.
6 imprinting region at 11p15.5 associated with Beckwith-Wiedemann syndrome.
7 nkage analysis to harbor the gene(s) for the Beckwith-Wiedemann syndrome.
8  Igf2 overexpression as a key determinant of Beckwith-Wiedemann syndrome.
9 ryonal tumors, including Wilms tumor, and in Beckwith-Wiedemann syndrome.
10 ilms' tumors, and tumors associated with the Beckwith-Wiedemann syndrome.
11 Prader-Willi syndrome, Angelman syndrome and Beckwith-Wiedemann syndrome.
12 abolic disorders such as type 2 diabetes and Beckwith-Wiedemann syndrome.
13 s in human p57(Kip2) have been implicated in Beckwith-Wiedemann syndrome, a disease that has also bee
14 ed expression of IGF2 has been implicated in Beckwith-Wiedemann syndrome, a human fetal overgrowth sy
15 se phenotypes are also seen in patients with Beckwith-Wiedemann syndrome, a pleiotropic hereditary di
16 them from the mutations of CDKN1C that cause Beckwith-Wiedemann syndrome, an overgrowth syndrome.
17 ome 11 at band p15.5, a region implicated in Beckwith-Wiedemann syndrome and a region of frequent los
18 s region to growth-related disorders such as Beckwith-Wiedemann syndrome and a variety of human cance
19 he mouse which will lead to animal models of Beckwith-Wiedemann syndrome and childhood tumours.
20                 p57(Kip2) has been linked to Beckwith-Wiedemann syndrome and IMAGe syndrome in humans
21 e p57(Kip2) locus has been implicated in the Beckwith-Wiedemann syndrome and in the development of sp
22 variant that was identified in a family with Beckwith-Wiedemann syndrome and MLID.
23 their occasional occurrence in patients with Beckwith-Wiedemann syndrome and the case presented here
24       This locus is of specific interest, as Beckwith-Wiedemann syndrome and various childhood and ad
25  lead to serious imprinting disorders (e.g., Beckwith-Wiedemann syndrome) and is described in some ca
26  test on 18 patients potentially affected by Beckwith-Wiedemann syndrome, and 17 individuals with cel
27 ART was found in registries of children with Beckwith-Wiedemann syndrome, Angelman syndrome, and reti
28 tes, a situation similar to that observed in Beckwith-Wiedemann syndrome, another imprinted disorder.
29 s associated with the developmental disorder Beckwith Wiedemann Syndrome (BWS) and with several cance
30 nd genotypes characterize the human disease, Beckwith--Wiedemann syndrome (BWS).
31 educed H19 expression and is associated with Beckwith--Wiedemann syndrome (BWS).
32 on and the two contrasting growth disorders, Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syn
33 sociated with the human imprinting disorders Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syn
34 , internal IC1 deletions are associated with Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syn
35 imprinted status of the genes in the region, Beckwith-Wiedemann syndrome (BWS) and Wilms tumor are ea
36                                Children with Beckwith-Wiedemann syndrome (BWS) are at increased risk
37 rearrangement breakpoints from patients with Beckwith-Wiedemann syndrome (BWS) have been mapped to 11
38 all report an unexpectedly high incidence of Beckwith-Wiedemann syndrome (BWS) in children conceived
39                                              Beckwith-Wiedemann syndrome (BWS) is a clinically variab
40                                              Beckwith-Wiedemann syndrome (BWS) is a congenital cancer
41                                              Beckwith-Wiedemann syndrome (BWS) is a fetal overgrowth
42                                              Beckwith-Wiedemann syndrome (BWS) is a hereditary human
43                                              Beckwith-Wiedemann syndrome (BWS) is a human stem cell d
44                                              Beckwith-Wiedemann syndrome (BWS) is a model human impri
45                                              Beckwith-Wiedemann syndrome (BWS) is an autosomal domina
46                                          The Beckwith-Wiedemann syndrome (BWS) is genetically linked
47                                          The Beckwith-Wiedemann syndrome (BWS) is marked by fetal org
48 mosome 11p15.1, centromeric to the imprinted Beckwith-Wiedemann syndrome (BWS) locus at 11p15.5.
49 1 that are associated with the human disease Beckwith-Wiedemann syndrome (BWS) may disrupt CDKN1C exp
50 ted with the Prader-Willi Syndrome (PWS) and Beckwith-Wiedemann Syndrome (BWS) where imprinting is kn
51 rearrangement breakpoints from patients with Beckwith-Wiedemann syndrome (BWS), a condition character
52 ncer and some hereditary diseases, including Beckwith-Wiedemann syndrome (BWS), a disorder of prenata
53 roblasts derived from patients with sporadic Beckwith-Wiedemann syndrome (BWS), a fetal overgrowth sy
54 enal defects, which are also features of the Beckwith-Wiedemann syndrome (BWS), a genetically complex
55            Disruption of imprinting leads to Beckwith-Wiedemann syndrome (BWS), an overgrowth and can
56                                              Beckwith-Wiedemann syndrome (BWS), which causes prenatal
57  chromosomal rearrangements in patients with Beckwith-Wiedemann syndrome (BWS), which causes prenatal
58          A related developmental disorder is Beckwith-Wiedemann syndrome (BWS), which increases risk
59                                              Beckwith-Wiedemann syndrome (BWS), which predisposes to
60 he normal kidney and tongue of patients with Beckwith-Wiedemann syndrome (BWS), which predisposes to
61 ted with a human overgrowth syndrome-namely, Beckwith-Wiedemann syndrome (BWS).
62 ergrowth and cancer predisposition condition Beckwith-Wiedemann syndrome (BWS).
63 of several pediatric and adult tumors and in Beckwith-Wiedemann syndrome (BWS).
64 und in the human foetal overgrowth syndrome, Beckwith-Wiedemann syndrome (BWS).
65 umor suppression and the cancer-predisposing Beckwith-Wiedemann syndrome (BWS).
66  cause of the imprinting overgrowth disorder Beckwith-Wiedemann Syndrome (BWS).
67 associated with imprinting disorders such as Beckwith-Wiedemann syndrome (BWS).
68 e patients with Prader-Willi syndrome (PWS), Beckwith-Wiedemann syndrome, Fragile-X syndrome, Angelma
69 ing guidelines for neurofibromatosis type 1, Beckwith-Wiedemann syndrome/ hemihypertrophy, and PTEN h
70  during childhood, including retinoblastoma, Beckwith-Wiedemann syndrome/idiopathic hemihypertrophy a
71 n of Igf2 results in most of the symptoms of Beckwith-Wiedemann syndrome, including prenatal overgrow
72                                          The Beckwith-Wiedemann syndrome is associated with the failu
73 implicated in the development of tumor-prone Beckwith-Wiedemann syndrome, is an effector molecule of
74 uency of ART conceptions among children with Beckwith-Wiedemann syndrome or Angelman syndrome caused
75 to develop rare epigenetic disorders such as Beckwith-Wiedemann Syndrome or Angelman Syndrome, both o
76 H analysis to map the breakpoints from three Beckwith-Wiedemann syndrome patients and a rhabdoid tumo
77  (ICR2), which is commonly hypomethylated in Beckwith-Wiedemann syndrome patients who exhibit massive
78 developing human brains and fibroblasts from Beckwith-Wiedemann syndrome patients.
79 actor, along with genetic conditions such as Beckwith-Wiedemann syndrome, Simpson-Golabi-Behmel syndr
80 n of human chromosome 11p15.5 is linked with Beckwith-Wiedemann syndrome that is associated with susc
81 ) we have found that the hereditary disorder Beckwith-Wiedemann syndrome, which predisposes to cancer
82 man chromosome 11p15.5, a region involved in Beckwith-Wiedemann syndrome, Wilms' tumor, and ovarian,